Many prognostic factors can influence the management plan. Lymph node metastasis is an important prognostic factor. Other factors include histology, size, and the patient's age. In a Surveillance, Epidemiology, and End Results (SEER) analysis of more than 2000 patients, the five-year disease-specific survival was 84% for stage I, 75% for stage II, and 57% for advanced tumors.